• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

该基因中的种系突变是家族性非髓样甲状腺癌的一个候选因素。

A Germline Mutation in the Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.

作者信息

Srivastava Aayushi, Miao Beiping, Skopelitou Diamanto, Kumar Varun, Kumar Abhishek, Paramasivam Nagarajan, Bonora Elena, Hemminki Kari, Försti Asta, Bandapalli Obul Reddy

机构信息

Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2020 Jun 1;12(6):1441. doi: 10.3390/cancers12061441.

DOI:10.3390/cancers12061441
PMID:32492864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7352431/
Abstract

Non-medullary thyroid cancer (NMTC) is a common endocrine malignancy with a genetic basis that has yet to be unequivocally established. In a recent whole-genome sequencing study of five families with occurrence of NMTCs, we shortlisted promising variants with the help of bioinformatics tools. Here, we report in silico analyses and in vitro experiments on a novel germline variant (p.V29L) in the highly conserved oligonucleotide/oligosaccharide binding domain of the () gene in one of the families. The results showed a reduction in telomere-bound POT1 levels in the mutant protein as compared to its wild-type counterpart. HEK293T cells carrying showed increased telomere length in comparison to wild-type cells, suggesting that the mutation causes telomere dysfunction and may play a role in predisposition to NMTC in this family. While one germline mutation in has already been reported in a melanoma-prone family with prevalence of thyroid cancers, we report the first of such mutations in a family affected solely by NMTCs, thus expanding current knowledge on shelterin complex-associated cancers.

摘要

非髓样甲状腺癌(NMTC)是一种常见的内分泌恶性肿瘤,其遗传基础尚未明确确立。在最近一项对五个发生NMTC的家族进行的全基因组测序研究中,我们借助生物信息学工具筛选出了有潜力的变异。在此,我们报告了对其中一个家族中()基因高度保守的寡核苷酸/寡糖结合域中的一个新型种系变异(p.V29L)进行的计算机分析和体外实验。结果显示,与野生型对应物相比,突变蛋白中端粒结合的POT1水平降低。携带的HEK293T细胞与野生型细胞相比,端粒长度增加,这表明该突变导致端粒功能障碍,可能在这个家族患NMTC的易感性中起作用。虽然在一个甲状腺癌患病率较高的易患黑色素瘤家族中已经报道了中的一个种系突变,但我们报告了在一个仅受NMTC影响的家族中首次出现这种突变,从而扩展了目前关于保护素复合物相关癌症的知识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f6/7352431/cd45d8dce3c5/cancers-12-01441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f6/7352431/cd45d8dce3c5/cancers-12-01441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/81f6/7352431/cd45d8dce3c5/cancers-12-01441-g001.jpg

相似文献

1
A Germline Mutation in the Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.该基因中的种系突变是家族性非髓样甲状腺癌的一个候选因素。
Cancers (Basel). 2020 Jun 1;12(6):1441. doi: 10.3390/cancers12061441.
2
Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.在家族性非髓样甲状腺癌的部分家族中 POT1 基因无突变。
Horm Cancer. 2020 Apr;11(2):111-116. doi: 10.1007/s12672-020-00383-5. Epub 2020 Mar 14.
3
Whole Genome Sequencing Prioritizes , and as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer.全基因组测序优先考虑家族性非髓样甲状腺癌的可能易患基因。
Front Endocrinol (Lausanne). 2021 Feb 22;12:600682. doi: 10.3389/fendo.2021.600682. eCollection 2021.
4
mutation spectrum in tumour types commonly diagnosed among -associated hereditary cancer syndrome families.肿瘤类型中的突变谱,在 - 相关遗传性癌症综合征家族中常见诊断。
J Med Genet. 2020 Oct;57(10):664-670. doi: 10.1136/jmedgenet-2019-106657. Epub 2020 Jan 14.
5
A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.一种新的端粒保护蛋白1(POT1)种系突变——扩展了与POT1相关癌症的谱。
Fam Cancer. 2017 Oct;16(4):561-566. doi: 10.1007/s10689-017-9984-y.
6
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.POT1 种系错义变异 p.I78T 与家族性黑色素瘤的关联。
JAMA Dermatol. 2019 May 1;155(5):604-609. doi: 10.1001/jamadermatol.2018.3662.
7
A Truncating Germline Mutation of in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres.甲状腺癌或黑色素瘤患者种系截断突变导致端粒更长。
Thyroid. 2020 Feb;30(2):204-213. doi: 10.1089/thy.2019.0156.
8
Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.端粒延长种系变异易患综合征型甲状腺乳头状癌亚型。
Am J Hum Genet. 2024 Jun 6;111(6):1114-1124. doi: 10.1016/j.ajhg.2024.04.006. Epub 2024 Apr 29.
9
Identification of a Cancer-Predisposing Germline p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma.通过对脾脏边缘区淋巴瘤的靶向测序鉴定出一个具有致癌潜力的胚系 p.Ile49Metfs*7 变异。
Genes (Basel). 2022 Mar 26;13(4):591. doi: 10.3390/genes13040591.
10
Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.两个霍奇金淋巴瘤家系中 Protection of Telomeres 1 的胚系突变。
Br J Haematol. 2018 May;181(3):372-377. doi: 10.1111/bjh.15203.

引用本文的文献

1
Relationship between affected family members and clinical aggressiveness in Familial non-medullary thyroid carcinoma: a systematic review and meta-analysis.家族性非髓样甲状腺癌中受影响家庭成员与临床侵袭性的关系:一项系统评价和荟萃分析
Endocrine. 2025 Sep 4. doi: 10.1007/s12020-025-04413-6.
2
Germline Variants in a Pan-Cancer Cohort.泛癌队列中的种系变异
JCO Precis Oncol. 2025 Jul;9:e2400946. doi: 10.1200/PO-24-00946. Epub 2025 Jul 9.
3
UK clinical practice guidelines for the management of patients with constitutional pathogenic variants.

本文引用的文献

1
Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.在家族性非髓样甲状腺癌的部分家族中 POT1 基因无突变。
Horm Cancer. 2020 Apr;11(2):111-116. doi: 10.1007/s12672-020-00383-5. Epub 2020 Mar 14.
2
Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.POT1 基因变异与甲状腺继发恶性肿瘤风险:来自儿童癌症幸存者研究的报告。
PLoS One. 2020 Feb 10;15(2):e0228887. doi: 10.1371/journal.pone.0228887. eCollection 2020.
3
Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways.
英国关于携带遗传性致病变异患者管理的临床实践指南。
J Med Genet. 2025 Jun 5. doi: 10.1136/jmg-2025-110638.
4
Identification and functional validation of a novel pathogenic germline variant p.G95V in familial melanoma.家族性黑色素瘤中一种新型致病性种系变体p.G95V的鉴定与功能验证
JEADV Clin Pract. 2024 Sep;3(4):1236-1239. doi: 10.1002/jvc2.382. Epub 2024 Feb 13.
5
Case report: Germline mutation in a patient with GIST and lung adenocarcinoma.病例报告:一名患有胃肠道间质瘤和肺腺癌患者的胚系突变。
Front Oncol. 2024 Aug 2;14:1419739. doi: 10.3389/fonc.2024.1419739. eCollection 2024.
6
POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program.POT1基因肿瘤易感性:相关恶性肿瘤的更广泛谱系及额外筛查方案建议
Eur J Hum Genet. 2024 Aug;32(8):980-986. doi: 10.1038/s41431-024-01611-0. Epub 2024 Jun 5.
7
Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer.非综合征性家族性甲状腺癌中突变基因的染色体定位
Front Oncol. 2024 Mar 20;14:1286426. doi: 10.3389/fonc.2024.1286426. eCollection 2024.
8
A Founder Variant Associated with Early Onset Recurrent Melanoma and Various Solid Malignancies.一种与早发性复发性黑色素瘤和多种实体恶性肿瘤相关的种系变异。
Genes (Basel). 2024 Mar 13;15(3):355. doi: 10.3390/genes15030355.
9
Association between thyroid disorders and extra-thyroidal cancers, a review.甲状腺疾病与甲状腺外癌症的关联:综述
Clin Transl Oncol. 2024 Sep;26(9):2075-2083. doi: 10.1007/s12094-024-03434-3. Epub 2024 Mar 15.
10
Identification of a Novel Germline Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma.家族性非髓样甲状腺癌中新发种系错义突变Asp409Asn的鉴定
Biomedicines. 2024 Jan 22;12(1):244. doi: 10.3390/biomedicines12010244.
家族性非髓样甲状腺癌的全基因组测序鉴定出 MAPK/ERK 和 PI3K/AKT 信号通路中的种系改变。
Biomolecules. 2019 Oct 13;9(10):605. doi: 10.3390/biom9100605.
4
Long telomeres and cancer risk: the price of cellular immortality.端粒较长与癌症风险:细胞不朽的代价。
J Clin Invest. 2019 Aug 5;129(9):3474-3481. doi: 10.1172/JCI120851.
5
Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer.非髓样甲状腺癌发生的胚系遗传风险因素的研究现状。
Genes (Basel). 2019 Jun 26;10(7):482. doi: 10.3390/genes10070482.
6
Leukocyte Telomere Length and Risk of Papillary Thyroid Carcinoma.白细胞端粒长度与甲状腺乳头状癌风险的关系。
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2712-2718. doi: 10.1210/jc.2018-02471.
7
Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.POT1 种系错义变异 p.I78T 与家族性黑色素瘤的关联。
JAMA Dermatol. 2019 May 1;155(5):604-609. doi: 10.1001/jamadermatol.2018.3662.
8
POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.胚系 POT1 基因突变而非 TERT 启动子突变与西班牙大型黑素瘤家系的黑素瘤易感性相关。
Br J Dermatol. 2019 Jul;181(1):105-113. doi: 10.1111/bjd.17443. Epub 2019 Feb 27.
9
Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.家族性非髓样甲状腺癌患者的疾病是否更具侵袭性?对初始手术治疗的影响。
Surgery. 2019 Jan;165(1):50-57. doi: 10.1016/j.surg.2018.05.075. Epub 2018 Oct 14.
10
Shelterin-Mediated Telomere Protection.端粒保护的庇护体机制。
Annu Rev Genet. 2018 Nov 23;52:223-247. doi: 10.1146/annurev-genet-032918-021921. Epub 2018 Sep 12.